Biberach an der Riss, Germany

Radoslaw Lipinski

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.2

ph-index = 1


Location History:

  • Ingelheim am Rhein, DE (2021)
  • Biberach an der Riss, DE (2022)

Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Radoslaw Lipinski: Innovator in Pharmaceutical Chemistry

Introduction

Radoslaw Lipinski is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of two patents to his name, Lipinski's work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Lipinski's latest patents include N-[(pyrimidinylamino)propanyl]-, N-[(pyridylamino)propanyl]-, and N-[(pyrazinylaminol)propanyl]arylcarboxamides. These inventions relate to novel compounds that have potential therapeutic uses, particularly in the treatment or prevention of conditions associated with the orexin sub-type 1 receptor. Additionally, he has developed difluoromethyl-phenyl triazoles, which are modulators of GABA receptors containing the α5 subunit. These compounds are useful in treating central nervous system diseases and other related conditions.

Career Highlights

Radoslaw Lipinski is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work has been instrumental in creating pharmaceutical compositions that enhance the efficacy of treatments for various diseases.

Collaborations

Some of Lipinski's notable coworkers include Doris Riether and Marco Ferrara. Their collaborative efforts contribute to the innovative research environment at Boehringer Ingelheim.

Conclusion

Radoslaw Lipinski is a prominent figure in pharmaceutical innovation, with a focus on developing novel compounds for therapeutic use. His contributions to the field are significant, and his ongoing work promises to impact the treatment of various medical conditions positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…